Healthpeak Properties, Inc. (NYSE:DOC) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eleven analysts that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $23.27.

Several equities research analysts recently issued reports on DOC shares. Wells Fargo & Company cut their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a report on Monday, June 2nd. Wedbush cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Scotiabank reduced their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. Argus restated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. Finally, Robert W. Baird cut their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th.

Healthpeak Properties Trading Down 0.7%

Shares of DOC traded down $0.13 during trading on Thursday, reaching $17.38. 4,888,301 shares of the company traded hands, compared to its average volume of 5,188,820. The stock has a 50-day simple moving average of $17.73 and a 200-day simple moving average of $19.41. The stock has a market cap of $12.07 billion, a PE ratio of 49.64, a price-to-earnings-growth ratio of 2.17 and a beta of 1.04. Healthpeak Properties has a twelve month low of $16.64 and a twelve month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same quarter last year, the firm earned $0.45 EPS. The firm's revenue for the quarter was up 15.9% on a year-over-year basis. On average, analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were given a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

Insider Buying and Selling

In other Healthpeak Properties news, CEO Scott M. Brinker bought 11,337 shares of the stock in a transaction dated Monday, April 28th. The shares were acquired at an average cost of $17.68 per share, for a total transaction of $200,438.16. Following the completion of the transaction, the chief executive officer now owns 201,863 shares in the company, valued at approximately $3,568,937.84. The trade was a 5.95% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Tommy G. Thompson bought 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The stock was acquired at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the acquisition, the director now directly owns 144,290 shares in the company, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 29,764 shares of company stock worth $521,909 over the last 90 days. 0.23% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Principal Financial Group Inc. lifted its position in Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the period. Norges Bank acquired a new position in shares of Healthpeak Properties during the fourth quarter worth about $166,804,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Healthpeak Properties by 584.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after purchasing an additional 7,872,150 shares in the last quarter. Nuveen LLC purchased a new position in Healthpeak Properties during the first quarter worth about $124,113,000. Finally, Resolution Capital Ltd acquired a new stake in Healthpeak Properties in the fourth quarter valued at about $122,795,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.